Moxetumomab pasudotox

(MOK-see-TOO-moh-mab pah-SOO-doh-tox) A drug used to treat hairy cell leukemia that came back or did not get better with at least two other systemic therapies, including treatment with a purine nucleoside analog (a type of anticancer drug). Moxetumomab pasudotox contains a monoclonal antibody called moxetumomab that binds to a protein called CD22, which is found on B cells (a type of white blood cell) and some types of leukemia cells. It also contains a bacterial toxin called PE38, which may help kill cancer cells. Moxetumomab pasudotox is a type of immunotoxin. Also called anti-CD22 immunotoxin CAT-8015, CAT-8015, and Lumoxiti.

• Dailymed label info on Moxetumomab pasudotox
• FDA Moxetumomab pasudotox

Moxetumomab pasudotox Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski